The Open Insulin Project: A Case Study for ‘Biohacked’ Medicines Jenna E. Gallegos, Christopher Boyer, Eleanore Pauwels, Warren A. Kaplan, Jean Peccoud Trends in Biotechnology Volume 36, Issue 12, Pages 1211-1218 (December 2018) DOI: 10.1016/j.tibtech.2018.07.009 Copyright © 2018 The Authors Terms and Conditions
Figure 1 Comparison of Traditional and DIYbio Manufacturing Models for Insulin. Differing shades of gray are used to demonstrate differing levels of complexity, cost, and risk, where the most complex, costly, and risky are shaded darkest, and the least complex, costly, and risky are shaded lightest. Trends in Biotechnology 2018 36, 1211-1218DOI: (10.1016/j.tibtech.2018.07.009) Copyright © 2018 The Authors Terms and Conditions